# Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder

> **NCT00773552** · PHASE4 · WITHDRAWN · sponsor: **Stamford Hospital**

## Conditions studied

- Urinary Urge
- Urge Incontinence
- Overactive Bladder

## Interventions

- **DRUG:** solifenacin succinate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00773552
- **Lead sponsor:** Stamford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator Left Institution
- **Last updated:** 2016-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773552, "Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00773552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*